Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Namjoshi
PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Palbociclib With Letrozole in Postmenopausal Women With ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial
Oncologist
Cancer Research
Medicine
Oncology
Genetic Polymorphism at Val80 (Rs700518) of the CYP19A1 Gene Is Associated With Aromatase Inhibitor Associated Bone Loss in Women With ER (+) Breast Cancer
Bone
Endocrinology
Physiology
Histology
Metabolism
Diabetes
Hypothyroidism Might Be Related to Breast Cancer in Post-Menopausal Women
Thyroid
Medicine
Endocrinology
Metabolism
Diabetes
Random-Start Ovarian Stimulation With Aromatase Inhibitor for Fertility Preservation in Women With Japanese Breast Cancer
Reproductive Medicine and Biology
Reproductive Medicine
Cell Biology
Lifetime Physical Activity and Risk of Breast Cancer in Pre-And Post-Menopausal Women
Breast Cancer Research and Treatment
Cancer Research
Oncology
Anastrozole as Aromatase Inhibitor – New Approaches to Breast Cancer Treatment in Postmenopausal Women
Nowotwory
Cancer Research
Oncology
Accumulation of P53 Is Prognostic for Aromatase Inhibitor Resistance in Early-Stage Postmenopausal Patients With ER-positive Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Performance of FRAX in Women With Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry‐Based Cohort Study
Journal of Bone and Mineral Research
Endocrinology
Orthopedics
Sports Medicine
Metabolism
Diabetes
Gene Expression Profiling of Response to mTOR Inhibitor Everolimus in Pre-Operatively Treated Post-Menopausal Women With Oestrogen Receptor-Positive Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
